Tumor-infiltrating CD8+ T cells exhibit higher purine biosynthesis activity than their counterparts in peripheral immune organs, and supplementation with one-carbon units has been shown to further enhance their anti-tumor capabilities [59]. The gene discussed is CD8A; the disease is neoplasm.